TWELVE DYNASTY

Brand	Owner (click to sort)	Address	Description
12 DYNASTY	CONCEPT CREATIVE	2221 77th Avenue N.E. Medina WA 98039	TWELVE DYNASTY;Beers;
12 DYNASTY	CONCEPT CREATIVE	2221 77th Avenue N.E. Medina WA 98039	TWELVE DYNASTY;Alcoholic beverages, except beer, namely, vodka, tequila, whisky, gin, rum, wine and distilled spirits;
12 DYNASTY	CONCEPT CREATIVE	2221 77th Avenue N.E. Medina WA 98039	TWELVE DYNASTY;Clothing, namely, T-shirts, shirts, pants, shorts, sweatsuits, jerseys, briefs, arm sleeves, caps, ponchos, capes, socks and footwear;
12 DYNASTY	CONCEPT CREATIVE	2221 77th Avenue N.E. Medina WA 98039	TWELVE DYNASTY;Promoting sports competitions and events of others;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention is directed to a method to prevent or reduce postoperative corneal subepithelial haze after excimer laser photorefractive keratectomy (PRK), laser in situ keratomileusis (LASIK) surgery. According to the method, a therapeutically effective amount of one or more plasminogen activators, most preferably urokinase (uPA), is administered topically to the surface of the affected eye at levels between 0.1 and 2,500 IU/ml, about eight to twelve times on the day of surgery, and four to eight times per day for about the next six to twelve days thereafter. The most preferred therapeutic amount is from about 0.1-1 IU uPA/ml, and also 1-10 IU/ml. Plasminogen activators that can be used in the inventions include urokinase, prourokinase, streptokinase and mutants thereof. The invention also covers topical ophthalmic compositions that include one or more plasminogen activators, most preferably uPA, to prevent or reduce postoperative corneal subepithelial haze.